Randomized Clinical Trial on Transanal Irrigation

Coloplast

Status: Completed

Conditions: Low Anterior Resection Syndrome

Treatments: Device: Peristeen cone catheter

Study type: Interventional

Funder types: Industry

Identifiers

NCT04586634

CP327

Details and patient eligibility

About

Objective The primary objective is to demonstrate superiority of the Peristeen cone catheter compared to standard of care.

The secondary objective is to investigate quality of life and different benefits and aspects of treatment and satisfaction with the Peristeen cone catheter.

Design of the investigation This is a randomised, open-label, parallel investigation comparing the Peristeen cone catheter with standard of care in subjects with major LARS (LARS score ≥ 30). Each subject will be enrolled for a study duration of 12 weeks. Subjects will be randomized to the treatments stratified by neo-adjuvant radiotherapy.

The comparator in this study will be current standard of care for patients with LARS which is conservative bowel management. This is defined as: Supportive therapy according to the individual treatment protocols available at each participating site.

Primary endpoint and secondary endpoints

Primary endpoint:

• LARS score, obtained from the LARS score questionnaire*

Secondary endpoints:

• Number of subjects with Major LARS*
• FIQL Score - scale 1, Modified American Society for Colorectal Surgeons Questionnaire*
• FIQL Score - scale 2, Modified American Society for Colorectal Surgeons Questionnaire*
• FIQL Score - scale 3, Modified American Society for Colorectal Surgeons Questionnaire*
• FIQL Score - scale 4, Modified American Society for Colorectal Surgeons Questionnaire*
• EQ-5D-5L - utility score*
• EQ-5D-5L - VAS score (scale 0-10 cm)*
• Satisfaction with treatment (scale 0-10 cm)*
• Number of adverse events* *All endpoints are measured per subject at study completion

Enrollment: 32 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Be at least 18 years of age and have full legal Capacity
2. Have given written informed consent
3. Be mental and physical capable to perform transanal irrigation with cone catheter
4. Have a LARS score ≥ 30 after rectal resection
5. Be treated according to individual treatment protocol for conservatory bowel management at participating site
6. Have proof of complete healing of the anastomosis by endoscopy or radiology before stoma closure
7. At least 3-months from last surgery in colorectum
8. Be evaluated to be suitable for transanal Irrigation procedure with a cone catheter by endoscopy, defecography or comparable procedure

Exclusion criteria

1. Active/recurrent colorectal cancer
2. Leaking anastomosis
3. Known anal or colorectal stenosis
4. Within 4 weeks of endoscopic polypectomy
5. Ischaemic colitis
6. Acute inflammatory bowel disease
7. Acute diverticulitis
8. Current or planned pregnancy

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

32 participants in 2 patient groups

Peristeen

Active Comparator group

Description:

Subjects to use newly developed Peristeen cone catherter device

Treatment:

Device: Peristeen cone catheter

Standard of care

No Intervention group

Description:

subjects continue with their standard of care treatment